Home
About Us
Subject
Browse
0
Sign In
Rituximab
Successful Treatment of Persistent Coronavirus Disease 2019 Infection in a Patient With Hypogammaglobulinemia With REGN-COV2: A Case Report
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Localized IgG4-related disease manifested on the tongue: a case report
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Noninfectious, Severe Cryoglobulinemic Vasculitis with Renal Involvement – Safety and Efficacy of Long-Term Treatment with Rituximab
Article
Year: 2021
Pages: 11
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Feasibility of therapeutic plasma exchange-based combination therapy in the treatment of acquired hemophilia A
A retrospective 6 case series
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Hydroxychloroquine and COVID-19: can we learn from the use of rituximab in systemic lupus erythematosus?
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Coronavirus disease 2019 in Latin American patients with multiple sclerosis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
Article
Year: 2021
Pages: 12
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
Article
Year: 2020
Pages: 10
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Refractory IgG4-related Pleural Disease with Chylothorax: A Case Report and Literature Review
Article
Year: 2021
Pages: 9
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Spectrum of Myelitis in Systemic Lupus Erythematosus: Experience from a Single Tertiary Care Centre over 25 Years
Article
Year: 2021
Pages: 8
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab
versus
mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice
Article
Year: 2021
Pages: 12
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: a Meta-analysis of Randomized Control Trials
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Systematic Review and Meta-Analysis of Rituximab for Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence?
Article
Year: 2021
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Optical Coherence Tomography Reveals Longitudinal Changes in Retinal Damage Under Different Treatments for Neuromyelitis Optica Spectrum Disorder
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia A successfully managed with rituximab – case report and review of the literature
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Phase III Clinical Trials in First-Line Follicular Lymphoma: A Review of Their Design and Interpretation
Article
Year: 2021
Pages: 17
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections)
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab induced cytokine release syndrome in an MS patient: A case report
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome
Article
Year: 2021
Pages: 11
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
Article
Year: 2021
Pages: 3
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Outcomes of diffuse large B-cell lymphoma in elderly patients—real-world experience from a middle-income country setting
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review.
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Plasma exchange with COVID-19 convalescent plasma in a patient with severe ANCA-associated vasculitis and COVID-19 pneumonia after rituximab therapy
Article
Year: 2021
Pages: 3
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Extended infusion of rituximab combined with steroids is effective in inducing remission and reducing relapse in adult minimal change disease
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667‐671”
Article
Year: 2021
Pages: 3
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Clinical Puzzles and Decision-Making in Antisynthetase Syndrome
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Fatal Human Infection with Evidence of Intrahost Variation of Eastern Equine Encephalitis Virus, Alabama, USA, 2019
Article
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Bilateral auricular nodules: A peculiar presentation of systemic mantle cell lymphoma
Article
Year: 2021
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A Rare Case of SARS-CoV-2-Induced Microscopic Polyangiitis
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report
Article
Year: 2021
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants
Article
Year: 2021
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Severe onset of inflammatory myositis in a child: think to paraneoplastic myositis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia, Focusing on Long Term Cytopenias Before and After the Era of Targeted Therapies
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab induced acute thrombocytopenia in a patient with systemic lupus erythematosus: a case report
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Unresponsive Thrombotic Thrombocytopenic Purpura (TTP): Challenges and Solutions
Article
Year: 2021
Pages: 11
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Evaluation of safety of rituximab in patients with multiple sclerosis: A retrograde study
Article
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Non-Coated Rituximab Induces Highly Cytotoxic Natural Killer Cells From Peripheral Blood Mononuclear Cells
via
Autologous B Cells
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Membranous Nephropathy With Monoclonal IgM Lambda Deposits in a Patient With IgM Monoclonal Gammopathy: A Case Report
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The Efficacy of High-Dose Dexamethasone vs. Other Treatments for Newly Diagnosed Immune Thrombocytopenia: A Meta-Analysis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intrathecal and systemic chemotherapy combined with rituximab
Article
Year: 2021
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Primary colonic lymphoma: report of two cases and a literature review
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review
Article
Year: 2021
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Case Report: Rituximab Improved Epileptic Spasms and EEG Abnormalities in an Infant With West Syndrome and Anti-NMDAR Encephalitis Associated With APECED
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
R-CHOP Chemotherapy for Disseminated
Mycobacterium avium
Complex Disease due to Anti-Interferon-Gamma Autoantibodies: A Case Report
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Anti-Muscle Specific Kinase (Anti-MuSK) Positive Myasthenia Gravis Overlapping With Parkinson’s Disease: A Challenging Diagnosis
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis
Article
Year: 2020
Pages: 13
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma
Article
Year: 2021
Pages: 10
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Combined Central and Peripheral Demyelinating Disease With Good Response to B-Cell Depleting Therapy
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Life-Threatening Subglottic Stenosis of Granulomatosis with Polyangiitis: A Case Report
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Successful low‐dose chemotherapy for refractory Epstein‐Barr virus—related post‐transplant lymphoproliferative disorder following hematopoietic stem cell transplantation in a child with Wiskott‐Aldrich syndrome
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell–Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy
Article
Year: 2021
Pages: 5
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
Article
Year: 2021
Pages: 21
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
Article
Year: 2020
Pages: 11
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A Case of Paraneoplastic Pemphigus as a Preceding Manifestation of Underlying Follicular Lymphoma Treated with R-CHOP
Article
Year: 2021
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Clinicopathologic features and treatment outcomes of patients with fibrillary glomerulonephritis
A case series
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Prolonged COVID-19 Disease in a Patient with Rheumatoid Arthritis on Rituximab Therapy
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Effective Early Treatment of AChR Antibody-Positive Myasthenia Gravis with Rituximab; the Experience from a Neuroimmunology Clinic in a Developing Country
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Fatal Enterovirus-related Myocarditis in a Patient with Devic’s Syndrome Treated with Rituximab
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Efficacy of Low-Dose Rituximab on Neuromyelitis Optica-Associated Optic Neuritis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation
Article
Year: 2021
Pages: 8
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A Pediatric Case of Granulomatous Myositis and Response to Treatment
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The first biological choice in patients with rheumatoid arthritis: data from the Moroccan register of biotherapies
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Case Report: Repeated Low-Dose Rituximab Treatment Is Effective in Relapsing Neuro Behçet's Disease
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A Novel Case of Cytomegalovirus Pneumonia in an Acquired Thrombotic Thrombocytopenic Purpura Patient Treated With Rituximab
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab Therapy for Treatment of Pemphigus in Southeast Asians
Article
Year: 2021
Pages: 14
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Successful treatment of PLA
2
R1-antibody positive membranous nephropathy with ocrelizumab
Article
Year: 2020
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Infantile giant cell hepatitis with autoimmune hemolytic anemia
Article
Year: 2021
Pages: 10
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Clinical Characteristics and Prognostic Factors of Children With Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic
Article
Year: 2021
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy
Article
Year: 2021
Pages: 12
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018
Article
Year: 2021
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Atypical presentation of immunoglobulin G4-related disease as subglottic stenosis: a case-based review
Article
Year: 2021
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
From Kidney to Brain: An Uncommon Severe Relapse of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody (MPO-ANCA) Vasculitis
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Potential of the tumor-derived extracellular vesicles carrying the miR-125b-5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab in Membranous Nephropathy
Article
Year: 2021
Pages: 13
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
Article
Year: 2021
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Vulvovaginal pyoderma gangrenosum associated with rituximab use in 2 patients with rheumatoid arthritis
Article
Year: 2021
Pages: 3
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Economic Evaluation of Rituximab + Recombinant Human Thrombopoietin vs. Rituximab for the Treatment of Second-Line Idiopathic Thrombocytopenic Purpura in China
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab-induced Ileocolitis in a Patient with Gastric MALToma: A Case Report and Literature Review
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
COVID-19 vaccination and antirheumatic therapy
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Acquired thrombotic thrombocytopenic Purpura diagnosed during first trimester of pregnancy with excellent outcome after plasma exchange and rituximab, a case report
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab for autoimmune retinopathy: Results of a Phase I/II clinical trial
Article
Year: 2020
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Low-dose rituximab protocol in rheumatoid arthritis—outcome and economic impact
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Can rituximab be used in the treatment of pemphigus vulgaris during the COVID‐19 pandemic?
Article
Year: 2020
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
Article
Year: 2020
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Bivalent binding on cells varies between anti-CD20 antibodies and is dose-dependent
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Rituximab use in adult glomerulopathies and its rationale
Article
Year: 2019
Pages: 17
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Load More
More Info